Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation advances the development of multiple myeloma treatments. Learn about multiple myeloma, MMRF research programs at themmrf.org
What is Myeloma - Multiple Myeloma Research Foundation
Multiple Myeloma is a blood cancer that affects the plasma cells in bone marrow. Multiple myeloma produces M proteins, interfering with the production of blood cells
multiple myeloma - National Cancer Institute
Information about multiple myeloma and other plasma cell neoplasms: treatment, clinical trials, research, and statistics from the National Cancer Institute.
Multiple Myeloma: International Myeloma Foundation
Research : The International Myeloma Foundation is the leader in globally collaborative myeloma research. The IMF is charting the course to a cure, mentoring the next ...
Multiple Myeloma: Johns Hopkins Sidney Kimmel ...
Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell. Plasma cells produce antibodies to help fight infection and disease.
What is multiple myeloma? What causes multiple myeloma ...
Multiple myeloma, also known as plasma cell myeloma, is a relatively uncommon cancer of the plasma cells - a type of white blood cell found within the bone marrow.
Multiple myeloma - Wikipedia, the free encyclopedia
Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. In multiple myeloma, collections of abnormal ...
Multiple Myeloma: Integrative Treatment Program | CTCA
A team approach to multiple myeloma treatment. At CTCA, we fight multiple myeloma with advanced medical treatments that help patients experience a better quality of life.
Multiple Myeloma News & Information - The Myeloma Beacon
Multiple myeloma news, resources, and online forums for patients, medical professionals, and others interested in multiple myeloma.
Multiple Myeloma — NEJM
Multiple myeloma is a neoplastic plasma-cell disorder that is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment ...